Double Medical Technology Inc (002901) — Cash Flow-to-Debt Ratio

Latest as of September 2025: 0.19x

Double Medical Technology Inc (002901) has a Cash Flow-to-Debt Ratio of 0.19x as of September 2025, meaning its operating cash flow of CN¥207.34 Million could theoretically repay 0% of its total liabilities (CN¥1.12 Billion) in one year. See 002901 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

0.19x
Operating CF / Total Liabilities

Operating Cash Flow

CN¥207.34 Million
CNY

Total Liabilities

CN¥1.12 Billion
CNY

Data as of

Sep 2025
Most recent filing

Double Medical Technology Inc Cash Flow-to-Debt Ratio (2013–2025)

Historical debt coverage capacity for Double Medical Technology Inc across 13 annual periods. For the full cash flow conversion analysis, see 002901 cash flow conversion.

Annual Cash Flow-to-Debt Ratio for Double Medical Technology Inc (2013–2025)

Year-by-year debt coverage analysis for Double Medical Technology Inc. Check Double Medical Technology Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Year CF-to-Debt Ratio Operating CF (CNY) Total Liabilities YoY Change
2025 0.67x CN¥831.34 Million CN¥1.24 Billion ▲ +87.7%
2024 0.36x CN¥442.30 Million CN¥1.24 Billion ▲ +615.6%
2023 0.05x CN¥73.89 Million CN¥1.48 Billion ▼ -67.7%
2022 0.15x CN¥128.44 Million CN¥831.15 Million ▼ -81.8%
2021 0.85x CN¥673.26 Million CN¥791.47 Million ▼ -21.7%
2020 1.09x CN¥555.77 Million CN¥511.72 Million ▲ +21.5%
2019 0.89x CN¥433.88 Million CN¥485.31 Million ▼ -44.7%
2018 1.62x CN¥334.88 Million CN¥207.22 Million ▼ -21.6%
2017 2.06x CN¥308.70 Million CN¥149.80 Million ▲ +38.2%
2016 1.49x CN¥207.13 Million CN¥138.93 Million ▲ +44.4%
2015 1.03x CN¥123.44 Million CN¥119.54 Million ▲ +85.1%
2014 0.56x CN¥151.12 Million CN¥270.92 Million ▼ -62.5%
2013 1.49x CN¥106.51 Million CN¥71.58 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.